New Orleans Saints quarterback Tyler Shough speaks with the media from the Ochsner Sports Performance Center on Wednesday, ...

Hill gathered in his only target for five yards and logged one rushing attempt for two yards during Sunday's 21-17 defeat to the Dolphins.

Watch New Orleans Saints quarterback Taysom Hill speak with the media live from the Ochsner Sports Performance Center after ...

Taysom Hill, at 35 years old, embodies versatility on the football field. Known primarily as a tight end, he also plays quarterback, wide receiver, and running back. This jack-of-all-trades approach ...

Kirk Cousins passed for 199 yards and two touchdowns in his second start this season, and the Atlanta Falcons ended a five-game skid with a 24-10 victory over the New Orleans Saints on Sunday.

GREENEVILLE, Tenn. (WJHL) – More than four years after Summer Wells was reported missing from her home in the Beech Creek Community of Hawkins County, the Tennessee Bureau of Investigation (TBI) ...

BOISE, Idaho, Nov. 17, 2025 /PRNewswire/ - Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) ("Perpetua Resources" or "Perpetua" or the "Company") announced today that its unaudited condensed ...

Star linebacker Anthony Hill Jr.’s status is up in the air after he suffered an undisclosed injury against the Bulldogs. Hill played most of the game, but the typically ever-present leader did miss ...

WASHINGTON COURT HOUSE, Ohio — Ohio Gov. Mike DeWine and first lady Fran DeWine visited Cherry Hill Primary School on Monday to highlight the district’s success in improving student literacy through ...

Rebecca Schleicher and Ben Hill's exits are the latest in a string of on-air personality departures from Nashville news stations. Many veteran journalists have left for personal reasons or to pursue ...

It has been zero days since the last Tyreek Hill drama. Currently out for the season with a knee injury sustained in Week 4, the Miami Dolphins wide receiver raised eyebrows Friday when it was noticed ...

Recent data presented at EASD and IPSAD provide further validation for SAB-142 as a novel, potentially best-in-class, disease-modifying, immunotherapeutic approach to redefine treatment of Stage 3 T1D ...